People with anxiety and depression are more prone to develop alcohol use disorder symptoms Dr. Kamal Kant Kohli5 May 2023 9:30 AM ISTUK: Individuals with anxiety or major depressive disorder experience more alcohol-related symptoms than people without those disorders who drink at...
Interpersonal therapy benefits pregnant women to combat depression: JAMA Aditi24 April 2023 5:15 AM ISTUnited States: An original investigation published in JAMA Psychiatry has addressed the role of IPT, brief interpersonal therapy, in depression among...
Medical Bulletin 1/April/2023 Isra Zaman1 April 2023 3:40 PM ISTHere are the top medical news for the day:CAR T cells improve patient quality of life: StudyChimeric antigen receptor T-cell (CAR-T) therapies are...
Trigger for major depression opens new possibilities for treatments Isra Zaman1 April 2023 9:45 AM ISTMajor depression is among the world's most urgent health needs. Its numbers have surged in recent years, especially among young adults. As...
Psilocybin significantly reduces major depressive disorder symptoms: Lancet Jacinthlyn Sylvia2 March 2023 8:00 PM ISTA new study by Robin von Rotz and team shows that for at least two weeks, a single modest dose of psilocybin dramatically lowers depressed symptoms....
Memory dysfunction in Major Depressive Disorder patients linked to lower Serotonin 4 Receptor Brain Binding: JAMA Aditi13 Feb 2023 11:00 AM ISTDenmark: An original investigation published in JAMA Psychiatry has answered a key point of serotonin 4 (5-HT4) receptor alteration in depression and...
Biogen, Sage Therapeutics get USFDA priority review for depression drug Zuranolone Ruchika Sharma7 Feb 2023 1:15 PM ISTZuranolone is an oral neuroactive steroid (NAS) GABA-A receptor positive allosteric modulator (PAM).
Phase 2a trial of psychedelic shows promise for major depressive disorder Medha Baranwal2 Feb 2023 8:00 PM ISTUK: Patients who received at least one active dose of SPL026 with supportive therapy showed a durable improvement in depression symptoms, according to...
Zydus Lifesciences arm bags USFDA approval for schizophrenia drug Brexpiprazole Ruchika Sharma14 Jan 2023 11:13 AM ISTThe drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India.
Chronic and severe depression linked to persistent cognitive dysfunction Jacinthlyn Sylvia5 Jan 2023 9:45 AM ISTRecent study conducted by Matcham and team showed that there is a connection between chronic depression severity and persistent cognitive difficulty....
JB Pharma bags USFDA nod for Major Depressive Disorder drug Venlafaxine Extended Release Ruchika Sharma30 Nov 2022 3:30 PM ISTA selective serotonin and norepinephrine reuptake inhibitor (SNRI), Venlafaxine Extended-Release tablets are indicated for Major Depressive Disorder...
Desvenlafaxine, paroxetine, venlafaxine, and vortioxetine efficacious and acceptable in stable MDD Dr. Kamal Kant Kohli1 Nov 2022 8:00 PM ISTJAPAN: According to a study that was published in the Journal, Molecular Psychiatry, the antidepressants desvenlafaxine, paroxetine, venlafaxine, and...
